What would be your preferred second line treatment for a frail elderly patient progressing on Rd?
Answer from: Medical Oncologist at Academic Institution
It will largely depend on the degree of frailty. Many of the myeloma therapeutics are well tolerated, even among older adults or those with comorbidities. Factors such as the time spent coming to clinic or to the infusion center matter as well. It is useful to understand the baseline cytogenetic abn...